Evommune logo

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 employees · est. 2020 · Palo Alto, United States

VS
Peptinnovate Ltd logo

Peptinnovate Ltd

2-10 employees · est. 2011

Peptinnovate Ltd is the older company (2020 vs 2011); Evommune is the larger of the two.

Side-by-Side Comparison

Evommune Peptinnovate Ltd
Founded
2020 2011 older
Headquarters
Palo Alto, United States Not tracked yet
Employees
69 larger 2-10
Industry
Biotechnology, Health Care, Life Sciences Health and Wellness, Pharmaceutical
Funding Stage
Unknown Series Unknown
Total Funding
$493.00M $4.01M
Funding Rounds
6 3
Services
Discovery and development of therapies for chronic inflammatory diseases, Pipeline advancement of product candidates, Hosting webinars and sharing scientific insights Not tracked yet
Target Customers
Patients with chronic inflammatory diseases, Healthcare professionals Not tracked yet
Taxonomy
Chronic Inflammatory Diseases, Innovative Therapies, Tissue-Based Approach, Transformative Medicines, Disease Progression Prevention, Inflammatory Disorders, Best-in-Class Profiles, Patient Care, Research And Development, Symptom Management, Healthcare Innovation, Therapeutic Development, Pipeline Development Immunology, Inflammatory Diseases, Drug Development, Therapeutics, Clinical Research, Safety, Efficacy, Chronic Inflammation, Therapy Development, Disease Modification, Remission, Clinical Trials, Pharmaceuticals, Healthcare Innovation
Website
evommune.com peptinnovate.com
Evommune logo

About Evommune

Evommune, founded in 2020, is a pioneering company in the fields of Biotechnology, Health Care, and Life Sciences, based in the United States. The company is making strides in addressing the pervasive challenge of chronic inflammation, which affects millions globally and is a precursor to numerous s...

Peptinnovate Ltd logo

About Peptinnovate Ltd

Peptinnovate Ltd, founded in 2011, is a pharmaceutical company that focuses on researching and developing innovative new therapies to address immuno-inflammatory diseases such as asthma, atopic dermatitis, and inflammatory bowel disease. These diseases are characterized by chronic inflammation, whic...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Evommune and Peptinnovate Ltd — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Evommune and Peptinnovate Ltd — by email.

Frequently Asked Questions

Evommune — Developing innovative therapies that target key drivers of chronic inflammatory diseases.. Peptinnovate Ltd. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Evommune has raised $493.00M while Peptinnovate Ltd has raised $4.01M.
Evommune and Peptinnovate Ltd operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Evommune with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy